Skip to main content

THERMO FISHER SCIENTIFIC INC.

For the period ended Sep 27, 2025. Filed Oct 31, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 27, 2025 · Filed Oct 31, 2025

TMO$718.20-0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Income

Three months endedNine months ended
September 27,September 28,September 27,September 28,
(In millions except per share amounts)2025202420252024
Revenues
Product revenues$6,489$6,148$18,719$18,266
Service revenues4,6334,45013,62313,218
Total revenues11,12210,59832,34131,484
Costs and operating expenses:
Cost of product revenues3,3193,1709,6839,189
Cost of service revenues3,2203,1009,4319,415
Selling, general and administrative expenses2,1622,0986,3806,392
Research and development expenses3463461,0411,016
Restructuring and other costs13545316151
Total costs and operating expenses9,1828,75926,85026,163
Operating income1,9411,8385,4915,321
Interest income234277735851
Interest expense(347)(356)(1,054)(1,073)
Other income/(expense)(2)(16)(18)(2)
Income before income taxes1,8261,7425,1555,096
Benefit from/(provision for) income taxes(207)(99)(394)(507)
Equity in earnings/(losses) of unconsolidated entities2(14)(9)(75)
Net income1,6211,6294,7514,514
Less: net income/(losses) attributable to noncontrolling interests and redeemable noncontrolling interest5—119
Net income attributable to Thermo Fisher Scientific Inc.$1,616$1,630$4,740$4,505
Earnings per share attributable to Thermo Fisher Scientific Inc.
Basic$4.28$4.26$12.55$11.79
Diluted$4.27$4.25$12.53$11.75
Weighted average shares
Basic378382378382
Diluted378384378383
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.